The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Placenta accreta and the risk of adverse maternal and neonatal outcomes
Abstract
Objective: Placenta accreta is an increasingly prevalent and potentially dangerous complication of pregnancy. Although most studies on the subject have addressed the risk factors for the development of this condition, evidence on maternal and neonatal outcomes for these pregnancies is scarce. The objective of the present study is to compile current evidence with regard to risk factors as well as adverse outcomes associated with placenta accreta. Methods: We conducted a complete literature review using PubMed, MEDLINE, Cochrane Database Reviews, UptoDate, DocGuide, as well as Google scholar and textbook literature for all articles on placenta accreta, and any one of the following keywords: “risk factors”, “maternal outcomes”, “neonatal outcomes”, “morbidity”, and “mortality”. Individual case reports were excluded. Results: We reviewed 34 studies conducted between 1977 and 2012. A total number of 508,617 deliveries were studied, with 865 cases of confirmed placenta accreta (average pooled incidence=1/588). The development of placenta accreta appears to be most strongly predicted by a history of cesarean section, low-lying placenta/previa, in vitro fertilization pregnancy, as well as elevated second-trimester levels of α-fetoprotein and β-human chorionic gonadotropin. The most significant maternal outcomes include the need for postpartum transfusion due to hemorrhage and peripartum hysterectomy. Maternal mortality remains rare but significantly higher than among matched, postpartum controls. Important neonatal outcomes include preterm birth, low birth weight, small for gestational age, and reduced 5-min Apgar scores. Whether the need for neonatal intensive care unit admission and steroid administration is iatrogenic and whether an increased risk of perinatal mortality is a clinically significant and independent outcome remain controversial. Conclusion: Although there is a significant shortage of studies on the subject, it appears that placenta accreta is associated with adverse maternal and neonatal outcomes, some of which may be life threatening. Prenatal diagnosis and adequate planning, particularly in high-risk populations, may be indicated for the reduction of these adverse outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other additional risk factors include maternal age 110,113,117,120 and ART, in particular in vitro fertilisation.113,120,122-125”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“Maternal mortality remains rare, but significantly higher than among matched postpartum controls.122”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“A review of 34 studies published between 1977 and 2012, including a total number of 508 617 deliveries and 865 cases of confirmed placenta accreta, found that the most significant maternal risks associated with delivery are the need for postpartum transfusion due to haemorrhage and peripartum hysterectomy.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“Attempts at removing placenta accreta at caesarean section can lead to massive haemorrhage, high maternal morbidity and possible maternal death.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“These risks are particularly high when the caesarean section takes place in an environment with no emergency access to blood bank products and expertise in managing placenta accreta.20,21,122,135”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries
Silver, R. M., Landon, M. B., Rouse, D. J., Leveno, K. J., Spong, C. Y., Thom, E. A., Moawad, A. H., Caritis, S. N., Harper, M., Wapner, R. J., et al. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000219750.79480.84 · Cited by 1,909 · cited 1×
“This effect is magnified when both risk factors are combined, that is, when placenta previa follows a history of cesarean section [5, 21, 31] .”
BackgroundAbnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331
Clinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106
Placenta previa/accreta and prior cesarean section.
Clark, S. L., Koonings, P. P., & Phelan, J. P. (1985) · PubMed · Cited by 712
Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta
Warshak, C. R., Eskander, R., Hull, A. D., Scioscia, A. L., Mattrey, R. F., Benirschke, K., & Resnik, R. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000233155.62906.6d · Cited by 515
Effect of Predelivery Diagnosis in 99 Consecutive Cases of Placenta Accreta
Warshak, C. R., Ramos, G. A., Eskander, R., Benirschke, K., Saenz, C. C., Kelly, T. F., Moore, T. R., & Resnik, R. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181c4f12a · Cited by 454
Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease
Jauniaux, E., & Jurkovic, D. (2012) · Placenta · doi:10.1016/j.placenta.2011.11.010 · Cited by 432
Pathophysiology of Placenta Creta: The Role of Decidua and Extravillous Trophoblast
Tantbirojn, P., Crum, C. P., & Parast, M. M. (2008) · Placenta · doi:10.1016/j.placenta.2008.04.008 · Cited by 428
Placenta Accreta—Summary of 10 Years: A Survey of 310 Cases
Gielchinsky, Y., Rojansky, N., Fasouliotis, S. J., & Ezra, Y. (2002) · Placenta · doi:10.1053/plac.2001.0764 · Cited by 376
Emergency peripartum hysterectomy
Zelop, C. M., Harlow, B. L., Frigoletto, F. D., Safon, L. E., & Saltzman, D. H. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90779-0 · Cited by 341
Effectiveness of Timing Strategies for Delivery of Individuals With Placenta Previa and Accreta
Robinson, B. K., & Grobman, W. A. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181f3588d · Cited by 276
Shih, J. C., Jaraquemada, J. M. P., Su, Y. N., Shyu, M. K., Lin, C. H., Lin, S. Y., & Lee, C. N. (2009) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6284 · Cited by 249
Placenta accreta: changing clinical aspects and outcome.
Read, J. A., Cotton, D. B., & Miller, F. C. (1980) · PubMed · Cited by 236
Risk factors for placenta accreta
Hung, T. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00460-8 · Cited by 205
Placenta accreta, increta, and percreta. A survey of 40 cases.
Breen, J. L., Neubecker, R. D., Gregori, C. A., & Franklin, J. A. (1977) · PubMed · Cited by 195
Dubois, J., Garel, L., Grignon, A., Lemay, M., & Leduc, L. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70582-9 · Cited by 193
Antenatal diagnosis of placenta accreta leads to reduced blood loss
TIKKANEN, M., PAAVONEN, J., LOUKOVAARA, M., & STEFANOVIC, V. (2011) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01147.x · Cited by 190
MRI appearance of placenta percreta and placenta accreta
Maldjian, C., Adam, R., Pelosi, M., Pelosi, M., Rudelli, R. D., & Maldjian, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(99)00035-1 · Cited by 170
Perinatal Outcome of Pregnancies Complicated by Placenta Accreta
Gielchinsky, Y., Mankuta, D., Rojansky, N., Laufer, N., Gielchinsky, I., & Ezra, Y. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136084.92846.95 · Cited by 161
Risks of Adverse Outcomes in the Next Birth After a First Cesarean Delivery
Kennare, R., Tucker, G., Heard, A., & Chan, A. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000250469.23047.73 · Cited by 153
Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
Zelop, C., Nadel, A., FRIGOLETTO, F. D., Pauker, S. P., MacMillan, M., & Benacerraf, B. R. (1992) · PubMed · Cited by 120
Pastore, M. B., Jobe, S. O., Ramadoss, J., & Magness, R. R. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1299597 · Cited by 89
Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
Kupferminc, M. J., Tamura, R. K., Wigton, T. R., Glassenberg, R., & Socol, M. L. (1993) · PubMed · Cited by 88
Optimal Management Strategies for Placenta Accreta
Eller, A., Porter, T. F., Soisson, P., & Silver, R. M. (2010) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000370525.13554.fd · Cited by 65
Is placenta accreta catching up with us?
Armstrong, C. A., Harding, S., MATTHEWS, T., & Dickinson, J. E. (2004) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2004.00208.x · Cited by 63
Second‐trimester maternal serum markers and placenta accreta
Dreux, S., Salomon, L. J., MULLER, F. M., Goffinet, F., Oury, J., ABA Study Group, & Sentilhes, L. (2012) · Prenatal Diagnosis · doi:10.1002/pd.3932 · Cited by 46
Indicated Preterm Birth for Placenta Accreta
Belfort, M. A. (2011) · Seminars in Perinatology · doi:10.1053/j.semperi.2011.05.002 · Cited by 45
Interpregnancy interval as a risk factor for placenta accreta.
Wax, J. R., Seiler, A., Horowitz, S., & INGARDIA, C. J. (2000) · PubMed · Cited by 41
Placenta accreta: depth of invasion and neonatal outcomes
Seet, E. L., Kay, H. H., Wu, S., & Terplan, M. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.678429 · Cited by 34
Maternal Outcome After Conservative Treatment of Placenta Accreta
Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., Perrotin, F., Winer, N., Pierre, F., Benachi, A., Dreyfus, M., et al. (2011) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000397116.74343.70 · Cited by 32
Ota, Y., Watanabe, H., Fukasawa, I., Tanaka, S., Kawatsu, T., Oishi, A., Yasuda, S., & Inaba, N. (1999) · Archives of Gynecology and Obstetrics · doi:10.1007/s004040050265 · Cited by 29
Pregnancies complicated by abnormally adherent placenta and sex ratio at birth.
Khong, T. Y., Healy, D. L., & McCloud, P. (1991) · BMJ · doi:10.1136/bmj.302.6777.625 · Cited by 29
Placenta accreta in Aba, south eastern, Nigeria.
Umezurike, C. C., & Nkwocha, G. (2007) · PubMed · Cited by 13
The outcome of placenta accreta in Kuwait (1981–1993)
Makhseed, M., & Moussa, M. A. A. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02418-c · Cited by 12
Risk factors of placenta accreta in Ile-Ife, Nigeria
Dare, F., & Oboro, V. (2003) · Nigerian Postgraduate Medical Journal · doi:10.4103/1117-1936.171630 · Cited by 6
[Analysis of placenta accreta risk factors. 8 case reports].
Sfar, E., Zine, S., Chaar, N. E., Ammar, K. B., Haouat, S., Zouari, F., Zitouna, M., & Chelli, H. (1994) · PubMed · Cited by 5
Placenta accreta/increta/percreta: incidence, risk factors, management and outcomes
Fitzpatrick, K., Sellers, S. M., Spark, P., Kurinczuk, J. J., Brocklehurst, P., & Knight, M. (2012) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fetalneonatal-2012-301809.11 · Cited by 3
Cited by
Jauniaux, E., Collins, S., & Burton, G. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.067 · Cited by 775
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology,
Jauniaux, E., Chantraine, F., Silver, R. M., Langhoff‐Roos, J., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12407 · Cited by 498
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
Jauniaux, E., Bunce, C., Grønbeck, L., & Langhoff-Roos, J. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.233 · Cited by 356
Proposal for standardized ultrasound descriptors of abnormally invasive placenta ( AIP )
Collins, S. L., Ashcroft, A., Braun, T., Calda, P., Langhoff‐Roos, J., Morel, O., Stefanovic, V., Tutschek, B., Chantraine, F., & on behalf of the European Working Group on Abnormally Invasive Placenta (EW‐AIP) (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14952 · Cited by 331
Metadata
- Authors
- Balayla, J., & Bondarenko, H. D.
- Affiliations
- Université de Montréal (CA)
- Corresponding author
- Balayla, Jacques
- ORCID
- Balayla, Jacques
- Venue
- jpme
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-12-15
- Volume
- 41
- Issue
- 2
- Pages
- 141-149
- ISSN
- 0300-5577 (ISSN-L)
- 1619-3997
- OpenAlex
- W2004529751
- Cited by
- 128
- References
- 37
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 10 · 2018: 16 · 2017: 11 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 5
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Perinatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- placenta accreta, placenta accreta spectrum, risk factors, maternal outcomes, neonatal outcomes, cesarean section, low-lying placenta, in vitro fertilization, alpha-fetoprotein, beta-hCG, postpartum hemorrhage, hysterectomy, maternal mortality, preterm birth, low birth weight, Apgar score, perinatal mortality, prenatal diagnosis
- MeSH terms
- Cesarean Section, Female, Postpartum Hemorrhage, Humans, Hysterectomy, Infant, Newborn, Placenta Accreta, Placenta Previa, Pregnancy, Pregnancy Outcome, Prenatal Diagnosis, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.